For patients with recurrent MEN1-related PHPT who do not meet surgical indications or refuse to be operated, cinacalcet can only maintain normal ranges of serum calcium and PTH, not reduce the risks of complications like fractures and kidney stones (28). This evidence concerns the gene PTH and nephrolithiasis.